Opal Wealth Advisors LLC Acquires 83 Shares of STERIS plc (NYSE:STE)

Opal Wealth Advisors LLC raised its holdings in shares of STERIS plc (NYSE:STE) by 7.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,161 shares of the medical equipment provider’s stock after purchasing an additional 83 shares during the period. Opal Wealth Advisors LLC’s holdings in STERIS were worth $261,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of STE. First Hawaiian Bank raised its position in shares of STERIS by 0.4% in the 1st quarter. First Hawaiian Bank now owns 13,857 shares of the medical equipment provider’s stock worth $3,115,000 after acquiring an additional 50 shares in the last quarter. Park Edge Advisors LLC increased its position in STERIS by 1.2% during the 4th quarter. Park Edge Advisors LLC now owns 4,409 shares of the medical equipment provider’s stock valued at $969,000 after buying an additional 51 shares in the last quarter. UMB Bank n.a. boosted its stake in STERIS by 7.8% during the 4th quarter. UMB Bank n.a. now owns 716 shares of the medical equipment provider’s stock valued at $157,000 after purchasing an additional 52 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund boosted its stake in STERIS by 1.5% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 3,520 shares of the medical equipment provider’s stock valued at $774,000 after purchasing an additional 53 shares during the last quarter. Finally, Legacy Wealth Asset Management LLC boosted its stake in STERIS by 1.5% during the 4th quarter. Legacy Wealth Asset Management LLC now owns 3,544 shares of the medical equipment provider’s stock valued at $779,000 after purchasing an additional 54 shares during the last quarter. Institutional investors own 94.69% of the company’s stock.

Insider Buying and Selling at STERIS

In other STERIS news, VP Renato Tamaro sold 1,154 shares of the firm’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $231.64, for a total transaction of $267,312.56. Following the sale, the vice president now directly owns 6,677 shares of the company’s stock, valued at $1,546,660.28. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other STERIS news, VP Renato Tamaro sold 1,154 shares of the firm’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $231.64, for a total transaction of $267,312.56. Following the sale, the vice president now directly owns 6,677 shares of the company’s stock, valued at $1,546,660.28. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Cary L. Majors sold 2,024 shares of the firm’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $232.13, for a total value of $469,831.12. Following the sale, the senior vice president now directly owns 11,369 shares in the company, valued at $2,639,085.97. The disclosure for this sale can be found here. Insiders have sold a total of 7,762 shares of company stock valued at $1,798,477 over the last ninety days. 1.14% of the stock is currently owned by company insiders.

STERIS Price Performance

Shares of STERIS stock opened at $218.12 on Monday. STERIS plc has a one year low of $195.47 and a one year high of $254.00. The stock’s fifty day moving average is $218.42 and its 200 day moving average is $220.68. The stock has a market cap of $21.56 billion, a P/E ratio of 57.10 and a beta of 0.85. The company has a debt-to-equity ratio of 0.49, a quick ratio of 2.36 and a current ratio of 3.08.

STERIS (NYSE:STE) last announced its earnings results on Wednesday, May 8th. The medical equipment provider reported $2.58 EPS for the quarter, topping analysts’ consensus estimates of $2.41 by $0.17. STERIS had a return on equity of 13.73% and a net margin of 6.95%. The company had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same period last year, the firm earned $2.30 EPS. STERIS’s revenue for the quarter was up 10.8% compared to the same quarter last year. Sell-side analysts anticipate that STERIS plc will post 9.24 earnings per share for the current year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 26th. Shareholders of record on Wednesday, June 12th will be issued a dividend of $0.52 per share. The ex-dividend date is Wednesday, June 12th. This represents a $2.08 dividend on an annualized basis and a yield of 0.95%. STERIS’s dividend payout ratio is presently 54.45%.

Analysts Set New Price Targets

Several brokerages have commented on STE. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research note on Friday, May 10th. JMP Securities restated a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a research note on Thursday, May 9th. Piper Sandler restated a “neutral” rating and issued a $225.00 price target (up from $220.00) on shares of STERIS in a research note on Friday, May 10th. Finally, StockNews.com upgraded STERIS from a “hold” rating to a “buy” rating in a research note on Saturday, June 15th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $241.60.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.